Overexpressions of Cyclin B1, cdc2, p16 and p53 in human breast cancer: the clinicopathologic correlations and prognostic implications (Q35003431)

5 August 2017

title

Overexpressions of Cyclin B1, cdc2, p16 and p53 in human breast cancer: the clinicopathologic correlations and prognostic implications (English)

1 reference

5 August 2017

1

Seoung Wan Chae

1 reference

5 August 2017

Jin Hee Sohn

2

1 reference

5 August 2017

Dong-Hoon Kim

3

1 reference

5 August 2017

Yoon Jung Choi

4

1 reference

5 August 2017

Yong Lai Park

5

1 reference

5 August 2017

Kyungeun Kim

6

1 reference

5 August 2017

Young Hye Cho

7

1 reference

5 August 2017

Jung-Soo Pyo

8

1 reference

5 August 2017

Jun Ho Kim

9

1 reference

5 August 2017

publication date

1 May 2011

1 reference

5 August 2017

published in

Yonsei Medical Journal

1 reference

5 August 2017

volume

52

1 reference

5 August 2017

issue

3

1 reference

5 August 2017

page(s)

445-453

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

5 August 2017

copyright license

start time

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Cancer statistics in Korea: incidence, mortality and survival in 2005.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101063

Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101063

High cyclin B1 expression is associated with poor survival in breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101063

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101063

Nuclear cyclin B1 in human breast carcinoma as a potent prognostic factor

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101063

Humoral immune response to p16, a cyclin-dependent kinase inhibitor in human malignancies.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101063

Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101063

Expression of the cell cycle regulatory proteins p34cdc2, p21waf1, and p53 in node negative invasive ductal breast carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101063

Cyclin B1 and CDK1: nuclear localization and upstream regulators

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101063

Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101063

A measure of the mitotic index: studies of the abundance and half-life of p34cdc2 in cultured cells and normal and neoplastic tissues

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101063

T-loop deletion of CDC2 from breast cancer tissues eliminates binding to cyclin B1 and cyclin-dependent kinase inhibitor p21.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101063

The role of p53 in cell cycle regulation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101063

Inhibitors of mammalian G1 cyclin-dependent kinases

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101063

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101063

Nuclear p53 Immunoreaction Associated with Poor Prognosis of Breast Cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101063

p53 function and dysfunction

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101063

Methylation status of p16 INK4A tumor suppressor gene in Iranian patients with sporadic breast cancer.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101063

Biological significance of allele specific loss of the p53 gene in breast carcinomas.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101063

Determination of the specific activity of CDK1 and CDK2 as a novel prognostic indicator for early breast cancer

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101063

p16INK4a modulates p53 in primary human mammary epithelial cells.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101063

Abnormal expression of pRb, p16, and cyclin D1 in gastric adenocarcinoma and its lymph node metastases: relationship with pathological features and survival.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101063

Prognostic significance of p16 and CDK4 proteins in localized prostate carcinoma

26 October 2018

1 reference

12 December 2020

An immunohistochemical study of p21 and p53 expression in primary node-positive breast carcinoma

1 reference

12 December 2020

Validation of p53 immunohistochemistry as a prognostic factor in breast cancer in clinical practice

1 reference

12 December 2020

Ordering S phase and M phase in the cell cycle

1 reference

12 December 2020

Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing

1 reference

12 December 2020

Increased expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product P16INK4A in ovarian cancer is associated with progression and unfavourable prognosis

1 reference

12 December 2020

Retinoblastoma and p16 proteins in mammary carcinoma: their relationship to cyclin D1 and histopathological parameters

1 reference

12 December 2020

Determination of the prognostic significance of cyclin B1 overexpression in patients with esophageal squamous cell carcinoma

1 reference

12 December 2020

Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer

1 reference

12 December 2020

Expression and prognostic role of cyclin-dependent kinase 1 (cdc2) in hepatocellular carcinoma

1 reference

12 December 2020

10.3349/YMJ.2011.52.3.445

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mio5sf5w4ja3bpl742rocvb4vi

30 July 2022

release_mio5sf5w4ja3bpl742rocvb4vi

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mio5sf5w4ja3bpl742rocvb4vi

30 July 2022

https://api.fatcat.wiki/v0/release/mio5sf5w4ja3bpl742rocvb4vi

1 reference

30 July 2022

https://api.fatcat.wiki/v0/release/mio5sf5w4ja3bpl742rocvb4vi

1 reference

30 July 2022